Iktos announces the appointment of Roman Fleck as Chairman of the Board of Directors. He brings an exceptional professional background with unvaluable experience in pharmaceutical research, investment and company leadership. His deep understanding of the biotech industry and broad network within the investment and pharma communities will be a strategic advantage for the development of Iktos. Follow the link for the full press release.